Botulinum Toxin Injection in Facial Paralysis and Other Neuromuscular Conditions

AbstractPurpose of ReviewBotulinum toxin A (BTX-A) has long been used for the management of the sequelae of facial paralysis and other neuromuscular conditions. Evidence is limited in its efficacy and outcomes, and there is a lack of standardisation in its use.Recent FindingsBoth objective and subjective outcomes in BTX-A injections for facial paralysis are favourable. Differences are seen depending on type of botulinum toxin used, but most studies recommend OnabotulinumtoxinA.SummaryBTX-A injection is an effective method in the treatment of these disorders, improving patient outcomes through a minimally invasive approach. There is however a paucity of randomised control trials and standardisation of protocols of its use.

Source: Current Otorhinolaryngology Reports - September 2, 2020 Category: ENT & OMF Source Type: research